Alex Jackson
3 posts
Apr 15, 2025
1:50 AM
|
At Medixo Centre, we recognize that cancer treatment costs, especially for medications like palbociclib, can place a significant burden on patients and their families. Palbociclib, a targeted therapy used primarily for treating hormone receptor-positive, HER2-negative breast cancer, is crucial for many patients, but its price can be a barrier to access. In the United States, the palbociclib price can range from $10,000 to $15,000 per month for a typical treatment regimen, depending on factors such as the dosage, healthcare provider, and patient insurance coverage.
While these prices may vary across different regions, the high cost remains a concern for many patients globally. At Medixo Centre, we are committed to offering more affordable options through partnerships with pharmaceutical manufacturers, discount programs, and by providing patients with transparent pricing. Our goal is to ensure that all patients have access to palbociclib without having to face overwhelming financial strain.
We believe that access to life-saving medications like palbociclib should not be dictated by cost, and we are dedicated to making cancer care more accessible and affordable for everyone.
Last Edited by Alex Jackson on Apr 15, 2025 1:53 AM
|
